Sundar PichaiSundar Pichai earned $164M in 2023

David Evans is the Interim Chief Executive Officer of Guardion Health Sciences, a company focused on innovative health products. He joined the company as a director in 2017 after the acquisition of his company, VectorVision, which specializes in vision testing....

Quick Links
G

David Evans

Ex-CEO of Guardion Health Sciences

Sector of Economy

Healthcare

CEO of Guardion Health Sciences for

0 years 6 months (Jun 2020 - Jan 2021)

Previous Experience

Unknown

Rivals

Competitors/colleagues of David Evans

Holdings

See how much did David Evans make over time.

David Evans is a significant stakeholder in Guardion Health Sciences, holding 3,050,000 shares, which accounts for about 7.56% of the company. This substantial ownership is primarily through VectorVision, a company he founded, which was acquired by Guardion in 2017. His...

Loading...

Insider Trading

See recent insider trades of David Evans.

No insider trades found for this CEO.

Compensation History

See how much did David Evans make over time.

David Evans' compensation for his role as Interim CEO in 2021 was $236,931, which primarily came from a base salary of $208,282. There were no bonuses or stock awards vested during this period, indicating a focus on stable salary rather than performance-based pay. This highlights a compensation strategy aligned with retaining talent without relying heavily on variable components that could influence decision-making. His total compensation also included $28,649 in other compensations, which suggests he receives benefits that go beyond salary. The absence of stock grants underscores a phase where the company is focusing on operational aspects over immediate financial incentives, possibly due to its growth stage. This compensation setup indicates that Evans is committed more to the company’s mission than personal financial gain at this point.

Year

2021

Total Compensation

$236.93K

Salary

$208.28K

Board Justification

The company aims to align executive compensation with performance and retention strategies, focusing on attracting and retaining key talent.

Bonus

$0.00

Board Justification

No bonus was awarded for the year 2021.

Other

$28.65K

Board Justification

Other compensation includes payments for consulting services and benefits.

Restricted Stock

$0.00(0 common stock)

Board Justification

No stock awards vested in 2021.

Performance Metrics

Performance metrics for 2021 were not specified in the provided information.

Other Guardion Health Sciences CEOs

Here are other CEOs of Guardion Health Sciences